Reverse haplotyping: taking full advantage of 25% risk testing for the 50% at-risk parent in Huntington’s disease
- DOI
- 10.1136/jmg-2026-111509
- Published
- 2026-04-09
- Container
- Journal of Medical Genetics
- Publisher
- BMJ
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1136/jmg-2026-111509,
title = {Reverse haplotyping: taking full advantage of 25\% risk testing for the 50\% at-risk parent in Huntington’s disease},
author = {Emilia K Bijlsma and Tamara T Koopmann and Susanne T de Bot and Monique Losekoot},
year = {2026},
journal = {Journal of Medical Genetics},
doi = {10.1136/jmg-2026-111509},
url = {https://doi.org/10.1136/jmg-2026-111509}
}RIS
TY - JOUR TI - Reverse haplotyping: taking full advantage of 25% risk testing for the 50% at-risk parent in Huntington’s disease AU - Emilia K Bijlsma AU - Tamara T Koopmann AU - Susanne T de Bot AU - Monique Losekoot PY - 2026 JO - Journal of Medical Genetics DO - 10.1136/jmg-2026-111509 UR - https://doi.org/10.1136/jmg-2026-111509 ER -
APA
Bijlsma, E. K., Koopmann, T. T., Bot, S. T. D., & Losekoot, M. (2026). Reverse haplotyping: taking full advantage of 25% risk testing for the 50% at-risk parent in Huntington’s disease. Journal of Medical Genetics. https://doi.org/10.1136/jmg-2026-111509
Source records
- crossref · retrieved 2026-09-26T03:53:09.413Z